Overview

The PATHFINDER Study: A Feasibility Trial

Status:
Completed
Trial end date:
2020-07-07
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether a rational strategy of EEG guided multimodal general anesthesia using target specific sedative and analgesics could result in enhanced recovery after anesthesia and surgery, decrease in postoperative delirium, and decrease in long term postoperative cognitive dysfunction up to 6 months following cardiac surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Treatments:
Dexmedetomidine
Ketamine
Propofol
Remifentanil
Rocuronium
Ropivacaine
Sevoflurane